Global Dosimetry Solutions, Inc. Appoints Donald Naab as President
29 8월 2006 - 4:00AM
PR Newswire (US)
SAN FRANCISCO, Aug. 28 /PRNewswire/ -- Global Dosimetry Solutions,
Inc. (GDS), a division of Mirion Technologies, today announced
Donald Naab has been appointed President. Effective today, Mr. Naab
fills the position held by Thomas Logan who was named Chairman and
CEO of Mirion Technologies in January 2006. GDS provides dosimetry,
consulting and system integration services for the nuclear and
medical industries. "We are thrilled that Don is joining GDS and
Mirion," said Thomas Logan, Chairman and CEO of Mirion
Technologies. "His style and experience make him ideally suited to
extend the strong growth legacy of GDS." "I am excited to join a
company with a rich history of success and bright future," stated
Naab, President of GDS. "Through the unparalleled caliber of our
people, we will continue to provide unmatched service to our
customers. We will build on our history focusing on key innovative
industry solutions." Most recently, Mr. Naab served as CEO of
Sanders Industries. He is a seasoned leader with over 20 years
experience in technology based companies ranging from the medical
and defense markets to energy management. Don holds a Bachelor of
Science degree in Electrical Engineering from the University of
Wisconsin-Madison and a Masters of Business Administration degree
from the University of Notre Dame. He is an active member of
several associations including IEEE, ACG, and Vistage and is on the
Board of OCEN. ABOUT MIRION TECHNOLOGIES Mirion Technologies
generated approximately $150 million in revenue from its diverse
global client base in 2005. The Company employs approximately 750
people worldwide, at its facilities in France, Germany, the United
Kingdom, Finland, China, Canada and the United States. Mirion
Technologies is headquartered in the San Francisco Bay area, and is
a portfolio company of American Capital Strategies (NASDAQ:ACAS).
DATASOURCE: Mirion Technologies CONTACT: Kimberly Croxson of Mirion
Technologies, +1-925-543-0806, Web site: http://www.dosimetry.com/
Copyright
American Capital Strategies (NASDAQ:ACAS)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
American Capital Strategies (NASDAQ:ACAS)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024